Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Identification of RET fusions in a Chinese multicancer retrospective analysis by next‐generation sequencingCancer science, 2022-01, Vol.113 (1), p.308-318 [Peer Reviewed Journal]2021 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2021 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15181 ;PMID: 34710947Full text available |
|
2 |
Material Type: Article
|
Osimertinib in Japanese patients with EGFR T790M mutation‐positive advanced non‐small‐cell lung cancer: AURA3 trialCancer science, 2018-06, Vol.109 (6), p.1930-1938 [Peer Reviewed Journal]2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13623 ;PMID: 29697876Full text available |
|
3 |
Material Type: Article
|
Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patientsJapanese journal of clinical oncology, 2018-07, Vol.48 (7), p.609-618 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2018 ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy069 ;PMID: 29767751Full text available |
|
4 |
Material Type: Article
|
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 studyJapanese journal of clinical oncology, 2018-11, Vol.48 (11), p.1012-1021 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2018 ;The Author(s) 2018. Published by Oxford University Press. 2018 ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy129 ;PMID: 30371895Full text available |
|
5 |
Material Type: Article
|
A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRCJapanese journal of clinical oncology, 2018-12, Vol.48 (12), p.1088-1095 [Peer Reviewed Journal]ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy136 ;PMID: 30257010Full text available |
|
6 |
Material Type: Article
|
Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subsetJapanese journal of clinical oncology, 2018-04, Vol.48 (4), p.367-375 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press. 2018 ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy016 ;PMID: 29474558Full text available |
|
7 |
Material Type: Article
|
Relation Between Identity Disclosure to Family Members and Mental Health in Japanese Transgender PeopleActa medica Okayama, 2021-10, Vol.75 (5), p.611-623 [Peer Reviewed Journal]ISSN: 0386-300X ;DOI: 10.18926/amo/62774 ;PMID: 34703044Full text available |
|
8 |
Material Type: Article
|
A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B classJapanese journal of clinical oncology, 2018-04, Vol.48 (4), p.317-321 [Peer Reviewed Journal]ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy010 ;PMID: 29474553Full text available |
|
9 |
Material Type: Article
|
NR3C1 gene polymorphisms are associated with high-altitude pulmonary edema in Han ChineseJournal of physiological anthropology, 2019-04, Vol.38 (1), p.4-4, Article 4 [Peer Reviewed Journal]COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1880-6805 ;ISSN: 1880-6791 ;EISSN: 1880-6805 ;DOI: 10.1186/s40101-019-0194-1 ;PMID: 30999951Full text available |
|
10 |
Material Type: Article
|
Loss of CD15 expression in clear cell renal cell carcinoma is correlated with worse prognosis in Chinese patientsJapanese journal of clinical oncology, 2017-12, Vol.47 (12), p.1182-1188 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx139 ;PMID: 29036563Full text available |
|
11 |
Material Type: Article
|
Osimertinib in patients with epidermal growth factor receptor T790M advanced non‐small cell lung cancer selected using cytology samplesCancer science, 2018-04, Vol.109 (4), p.1177-1184 [Peer Reviewed Journal]2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2018. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13511 ;PMID: 29363250Full text available |
|
12 |
Material Type: Article
|
Prevalence and molecular characteristics of defective mismatch repair epithelial ovarian cancer in a Japanese hospital-based populationJapanese journal of clinical oncology, 2018-08, Vol.48 (8), p.728-735 [Peer Reviewed Journal]ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy081 ;PMID: 29889250Full text available |
|
13 |
Material Type: Article
|
First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trialJapanese journal of clinical oncology, 2017-05, Vol.47 (5), p.385-392 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx001 ;PMID: 28158579Full text available |
|
14 |
Material Type: Article
|
Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subsetJapanese journal of clinical oncology, 2017-07, Vol.47 (7), p.618-624 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx045 ;PMID: 28369553Full text available |
|
15 |
Material Type: Article
|
Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumorsJapanese journal of clinical oncology, 2018-04, Vol.48 (4), p.322-328 [Peer Reviewed Journal]ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy026 ;PMID: 29514256Full text available |
|
16 |
Material Type: Article
|
Trends in the quality assurance process indicators for Japanese colorectal cancer screening during 2003–13Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.329-334 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2018 ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy022 ;PMID: 29506049Full text available |
|
17 |
Material Type: Article
|
Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemiaJapanese journal of clinical oncology, 2017-01, Vol.47 (1), p.54-60 [Peer Reviewed Journal]The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyw146 ;PMID: 28122892Full text available |
|
18 |
Material Type: Article
|
Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trialJapanese journal of clinical oncology, 2017-06, Vol.47 (6), p.551-559 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press. ;The Author 2017. Published by Oxford University Press. 2017 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyw194 ;PMID: 28334974Full text available |
|
19 |
Material Type: Article
|
Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinomaCancer science, 2021-01, Vol.112 (1), p.305-313 [Peer Reviewed Journal]2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14681 ;PMID: 33047430Full text available |
|
20 |
Material Type: Article
|
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 studyCancer science, 2020-02, Vol.111 (2), p.513-527 [Peer Reviewed Journal]2019 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14264 ;PMID: 31789476Full text available |